Viewing nowCozartan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 200600521 · Notified 2006.02.08 · Insurance code 661901600
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used for the treatment of hypertension and is particularly helpful in managing kidney disease in patients with type 2 diabetes who have hypertension. It effectively controls blood pressure to prevent the deterioration of kidney function and improves overall vascular health. Thus, it plays an important role in preventing complications related to hypertension.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be given orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive (e.g., a low-dose diuretic). An additive effect was observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients being treated with diuretics) (see the Precautions for Use section). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older, patients weighing 20 kg or more and less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older, patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. There is a risk of reduced amniotic fluid, potential lung development issues or skeletal malformations in the fetus. Newborns may exhibit conditions such as cranial formation impairment, reduced kidney function, and hypotension, so caution is advised. This drug should not be administered to individuals with known allergies to this medication or its ingredients, pregnant women or those who may become pregnant, patients with severe liver dysfunction, individuals with a history of angioedema, or patients with certain genetic disorders. Additionally, patients with moderate to severe impairment in kidney function or diabetes should avoid using this drug in combination with specific medications. Caution should be exercised when using this medication in elderly patients, those with hyperkalemia, liver dysfunction, heart valve disease, and patients with reduced blood volume. While this medication is safe for most patients, side effects such as dizziness, muscle cramps, back pain, upper respiratory infections, etc., may occur. Rarely, serious side effects such as angioedema, liver dysfunction, muscle damage, severe hypotension, or renal failure may arise, so any unusual symptoms should be discussed with a doctor immediately. This drug may affect liver or kidney function, thus regular blood tests and monitoring of physical condition are essential. Particularly, as hyperkalemia may occur, potassium levels should be regularly checked, and the use of potassium supplements or potassium-containing foods should be avoided. This medication may interact with other antihypertensive agents or specific medications, so inform your healthcare provider if you are taking any other medications. During treatment, be cautious of symptoms such as dizziness or drowsiness when driving or operating machinery, and the dosing increase should be monitored and done cautiously. Women who are pregnant or breastfeeding should avoid the use of this medication, and in unavoidable situations, appropriate measures should be taken after consulting with healthcare professionals. It is recommended that children under 6 years of age or children with severely impaired kidney function do not use this medication. In cases of overdose, hypotension and bradycardia may occur, and immediate medical attention should be sought. This medication should be stored out of reach of children and not transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the drug.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.